Related Experiment Video
Updated: Jan 29, 2026

Author Spotlight: High-Throughput Image-Based Quantification of Mitochondrial DNA Synthesis and Distribution
Published on: May 5, 2023
Altered cord blood mitochondrial DNA content and pregnancy lead exposure in the PROGRESS cohort
Marco Sanchez-Guerra1, Cheng Peng2, Letizia Trevisi3
1Department of Developmental Neurobiology, National Institute of Perinatology, Montes Urales 800, Lomas Virreyes, Mexico City 11000, Mexico.
Insights
Lead exposure during pregnancy increases mitochondrial DNA (mtDNA) content in cord blood, suggesting a potential mechanism for lead
Area of Science:
- Environmental Health Sciences
- Reproductive Biology
- Toxicology
Background:
- Lead (Pb) exposure during pregnancy poses risks including oxidative stress, reduced fetal growth, and neurological issues.
- Mitochondria are the primary source of oxidative stress, and their dysfunction is implicated in lead toxicity.
- Mitochondrial DNA (mtDNA) content serves as a sensitive indicator of mitochondrial function.
Purpose of the Study:
- To investigate the association between prenatal lead exposure and mtDNA content in umbilical cord blood.
- To explore potential mechanisms of lead's adverse effects on fetal development through mitochondrial function.
Main Methods:
- Analysis of mother-infant pairs from the prospective PROGRESS birth-cohort study in Mexico City.
- Quantification of relative mtDNA content (mtDNA/nuclear DNA ratio) in cord blood using quantitative PCR.
- Measurement of lead concentrations in maternal and cord blood via ICP-MS, with multivariable regression adjusting for confounders.
Main Results:
- Maternal blood lead levels in the second and third trimesters, and cord blood lead levels, were significantly associated with increased cord blood mtDNA content.
- A mean increase of 0.050 in mtDNA content was observed per 1 μg/dL increase in cord blood lead.
- Cord blood lead showed a marginal interaction with gestational age, increasing mtDNA content particularly in preterm births.
Conclusions:
- Prenatal lead exposure is linked to altered mtDNA content in umbilical cord blood.
- Changes in mtDNA content may represent a key mechanism through which lead exerts its toxicity during pregnancy.
- This finding highlights the impact of environmental lead exposure on fetal mitochondrial health.
Introduction:
Lead (Pb) crosses the placenta and can cause oxidative stress, reduced fetal growth and neurological problems. The principal source of oxidative stress in human cells is mitochondria. Therefore, disruption of normal mitochondrial function during pregnancy may represent a primary mechanism behind the adverse effects of lead. We sought to assess the association of Pb exposure during pregnancy with mitochondrial DNA (mtDNA) content, a sensitive marker of mitochondrial function, in cord blood.
Materials And Methods:
This study comprised mother-infant pairs from the Programming Research in Obesity, Growth, Environment and Social Stressors (PROGRESS) study, a prospective birth-cohort that enrolled 1050 pregnant women from Mexico City who were receiving prenatal care between December 2007 and July 2011. Quantitative PCR was used to calculate relative MtDNA content (mitochondrial-to-nuclear DNA ratio (mtDNA/nDNA)) in cord blood. Lead concentrations in both maternal blood (2nd and 3rd trimester and at delivery day) and in cord blood were measured by ICP-MS. Multivariable regression models adjusting for multiple confounders were fitted with 410 mother-infant pairs for whom complete data for mtDNA content, lead levels, and covariates were available.
Results:
Maternal blood Pb measured in the second (mean 3.79 μg/dL, SD 2.63; β = 0.059, 95% CI 0.008, 0.111) and third trimester (mean 3.90 μg/dL; SD 2.84; β = 0.054, 95% CI 0.002, 0.107) during pregnancy and PB in cord blood (mean 3.50 μg/dL, SD 2.59; β = 0.050, 95% CI 0.004; 0.096) were associated with increased cord blood mtDNA content (mean 1.46, SD 0.44). In two-way interaction analyses, cord blood Pb marginally interacted with gestational age leading to an increase in mtDNA content for pre-term births (Benjamini-Hochberg False Discovery Rate correction; BH-FDR = 0.08).
Conclusion:
This study shows that lead exposure in pregnancy alters mtDNA content in cord blood; therefore, alteration of mtDNA content might be a mechanism underlying the toxicity of lead.
Related Concept Videos
Alterations in Blood Pressure
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart...
Animal Mitochondrial Genetics
Export of Mitochondrial and Chloroplast Genes
Comparing Mitochondrial, Chloroplast, and Prokaryotic Genomes
Stereotype Content Model
Alterations in Respiration II
In Biot's breathing, the respiratory rate and depth are irregular, alternating between periods of deep gasping and apnea. Common causes...

